| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Revenue | $29.14B | +2.2% |
| R&D Expense | $2.35B | +14.9% |
| SG&A Expense | $5.16B | +4.4% |
| Operating Income | $2.09B | +167.1% |
| Interest Expense | $709.0M | +50.5% |
| Pre-tax Income | $2.23B | +154.6% |
| Income Tax | $205.0M | +2462.5% |
| Net Income | $2.02B | +133.3% |
| EPS (Basic) | $1.56 |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.27B | +2.6% |
| Accounts Receivable | $3.48B | -15.1% |
| Inventory | $4.61B | -10.7% |
| Current Assets | $18.95B | -7.6% |
| Total Assets | $57.15B | +0.1% |
| Current Liabilities | $21.88B | -5.6% |
| Long-term Debt | $11.69B | -2.1% |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.43B | -3.6% |
| Investing Cash Flow | -$3.28B | -57.4% |
| Financing Cash Flow | -$1.36B | +24.2% |
| +132.8% |
| EPS (Diluted) | $1.54 | +133.3% |
| Stockholders' Equity |
| $21.18B |
| +6.6% |